Angiogenin negatively regulates the expression of basic fibroblast growth factor (bFGF) and inhibits bFGF promoter...

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• Angiogenin and basic fibroblast growth factor (bFGF) are key angiogenic factors implicated in tumor growth and metastasis.
• The precise regulatory mechanism between angiogenin and bFGF expression remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which angiogenin regulates bFGF expression.
• To identify specific interactions and regulatory sites involved in this process.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot to assess bFGF expression.
• Immunofluorescence staining and immune electron microscopy for angiogenin nuclear translocation.
• Site-directed mutagenesis, reporter gene assays, and electrophoretic mobility shift assay (EMSA) for promoter analysis.

Main Results:

• Angiogenin was found to negatively regulate bFGF expression in HeLa cells.
• Angiogenin undergoes nuclear translocation.
• A specific angiogenin binding site (CTCTCTCT) was identified on the bFGF promoter, and angiogenin inhibited promoter activity.

Conclusions:

• Angiogenin directly inhibits bFGF gene expression through binding to its promoter.
• Understanding this regulatory axis is crucial for developing novel therapeutic strategies targeting tumor angiogenesis.